Skip to main content
OpenTrials

Clinical trial condition

Chemotherapy-induced Nausea and Vomiting

Explore clinical trials studying Chemotherapy-induced Nausea and Vomiting. Study availability and eligibility vary by location and protocol.

86 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Chemotherapy-induced Nausea and Vomiting trial results

Completed

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

NCT02106494

Conditions
Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations
  • Arizona Oncology Associates, PC-HAL Phoenix, Arizona, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • Compassionate Cancer Medical Center Riverside, California, United States
  • Northern Indiana Research Mishawaka, Indiana, United States
View Trial Details
Completed

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

NCT04817189

Conditions
Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations
  • Shanghai Chest Hospital Shanghai, China
  • Shanghai Ninth People´s Hospital Shanghai, China
  • Shanghai Obstetrics and Gynecology Hospital Shanghai, China
  • Thomayerova nemocnice Prague, Czechia
View all 19 locations
View Trial Details
Completed

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

NCT03984214

Conditions
Chemotherapy-induced Nausea and Vomiting, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Hanusch Krankenhaus der Wiener Gebietskrankenkasse Vienna, State of Vienna, Austria
  • Klinikum Wels-Grieskirchen GmbH, Abteilung für Innere Medizin IV Wels, Upper Austria, Austria
  • KABEG-Klinikum Klagenfurt am Woerthersee, Abteilung f. Anaesthesie u. Intensivmedizin Klagenfurt, Austria
View Trial Details
Completed

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

NCT04054193

Conditions
Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations
  • Phoenix Childrens Hospital ( Site 1101) Phoenix, Arizona, United States
  • Southern California Permanente Medical Group ( Site 1104) Los Angeles, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 1106) Chicago, Illinois, United States
  • Children's Hospitals and Clinics of Minnesota ( Site 1109) Minneapolis, Minnesota, United States
View all 26 locations
View Trial Details

Related conditions